WELL Stock Analysis: Welltower | NYSE
REIT - Healthcare Facilities | NYSE, USA | Market Cap: 163.368m USD | 12M Return: 28.3% | US95040Q1040 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 577M
EPS Trend: 96.2%
Qual. Beats: 0
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Welltower Inc. (NYSE: WELL) is a S&P 500 healthcare REIT that owns and operates a portfolio of 2,000+ senior housing and wellness communities across the United States, United Kingdom, and Canada, primarily serving aging renters through a rental housing model. The company describes itself as an operating company in a real estate wrapper, combining real estate ownership with active property operations supported by a proprietary data science platform and its internal Welltower Business System.
The healthcare REIT subsector in which Welltower operates invests in real estate assets tied to the healthcare services industry, with senior housing operators leasing properties from the REIT under triple-net or RIDEA-style structures. Demographic tailwinds from the aging population in North America and Western Europe are a key structural driver for senior housing REITs. Welltower was incorporated in Delaware in 1970 and is headquartered in Toledo, Ohio.
- Senior housing occupancy and RevPOR growth expand SHOP segment margins
- Higher interest rates compress acquisition spreads and cap rate economics
- Baby boomer demographics fuel long-term senior housing demand growth
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.75 > 1.0 |
| NWC/Revenue: 25.30% < 20% (prev 92.92%; Δ -67.62% < -1%) |
| CFO/TA 0.04 > 3% & CFO 2.88b > Net Income 1.46b |
| Net Debt (19.0b) to EBITDA (3.33b): 5.70 < 3 |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (754.9m) vs 12m ago 10.14% < -2% |
| Gross Margin: 52.64% > 18% (prev 38.85%; Δ 13.79% > 0.5%) |
| Asset Turnover: 20.57% > 50% (prev 16.39%; Δ 4.18% > 0%) |
| Interest Coverage Ratio: 0.83 > 6 (EBIT TTM 643.1m / Interest Expense TTM 771.1m) |
| A: 0.05 (Total Current Assets 5.32b - Total Current Liabilities 1.86b) / Total Assets 73.7b |
| B: -0.12 (Retained Earnings -9.16b / Total Assets 73.7b) |
| C: 0.01 (EBIT TTM 643.1m / Avg Total Assets 66.6b) |
| D: 2.04 (Book Value of Equity 48.6b / Total Liabilities 23.8b) |
| Altman-Z'' = 2.11 = BBB |
| DSRI: 0.52 (Receivables 3.05b/4.15b, Revenue 13.7b/9.75b) |
| GMI: 0.74 (GM 38.85% / 52.64%) |
| AQI: 1.14 (AQ_t 0.90 / AQ_t-1 0.79) |
| SGI: 1.40 (Revenue 13.7b / 9.75b) |
| TATA: -0.02 (NI 1.46b - CFO 2.88b) / TA 73.7b) |
| Beneish M = -3.29 (Cap -4..+1) = AA |
As of October 29, 2026, the stock is trading at USD 227.20 with a total of 5,850,324 shares traded. Over the past week, the price has changed by -2.98%, over one month by -2.47%, over three months by -6.37% and over the past year by +28.29%.
Current recommended Stop Loss: 213.60 (which is 6% or 2.4 ATR below the current price).
Welltower has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy WELL.
- StrongBuy: 12
- Buy: 6
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 260.2 | 14.5% |
P/E Trailing = 100.3186
P/E Forward = 81.3008
P/S = 12.7999
P/B = 3.7354
P/EG = 3.6218
Revenue TTM = 13.7b USD
EBIT TTM = 643.1m USD
EBITDA TTM = 3.33b USD
Long Term Debt = 19.2b USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 21.2b USD (corrected: LT Debt 19.2b + ST Debt none) + Leases 2.05b
Net Debt = 19.0b USD (calculated: Debt 21.2b - CCE 2.27b)
Enterprise Value = 182b USD (163b + Debt 21.2b - CCE 2.27b)
Interest Coverage Ratio = 0.83 (Ebit TTM 643.1m / Interest Expense TTM 771.1m)
EV/FCF = 64.03x (Enterprise Value 182b / FCF TTM 2.85b)
FCF Yield = 1.56% (FCF TTM 2.85b / Enterprise Value 182b)
FCF Margin = 20.79% (FCF TTM 2.85b / Revenue TTM 13.7b)
Net Margin = 10.67% (Net Income TTM 1.46b / Revenue TTM 13.7b)
Gross Margin = 52.64% ((Revenue TTM 13.7b - Cost of Revenue TTM 6.49b) / Revenue TTM)
Gross Margin QoQ = none% (prev 39.34%)
Tobins Q-Ratio = 2.47 (Enterprise Value 182b / Total Assets 73.7b)
Interest Expense / Debt = 3.63% (Interest Expense 771.1m / Debt 21.2b)
Taxrate = 4.01% (61.5m / 1.53b)
NOPAT = 617.3m (EBIT 643.1m * (1 - 4.01%))
Current Ratio = 2.87 (Total Current Assets 5.32b / Total Current Liabilities 1.86b)
Debt / Equity = 0.44 (Debt 21.2b / totalStockholderEquity, last quarter 48.6b)
Debt / EBITDA = 5.70 (Net Debt 19.0b / EBITDA 3.33b)
Debt / FCF = 6.66 (Net Debt 19.0b / FCF TTM 2.85b)
Total Stockholder Equity = 45.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 1.46b / Total Assets 73.7b)
RoE = 3.23% (Net Income TTM 1.46b / Total Stockholder Equity 45.2b)
RoCE = 1.00% (EBIT 643.1m / Capital Employed (Equity 45.2b + L.T.Debt 19.2b))
RoIC = 0.87% (NOPAT 617.3m / Invested Capital 71.2b)
WACC = 5.10% (E(163b)/V(185b) * Re(5.31%) + D(21.2b)/V(185b) * Rd(3.63%) * (1-Tc(0.04)))
Discount Rate = 5.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.76 | Cagr: 10.37%
[DCF] Terminal Value 75.92% ; FCFF base≈2.81b ; Y1≈2.91b ; Y5≈3.27b
[DCF] Fair Price = 43.81 (EV 50.5b - Net Debt 19.0b = Equity 31.6b / Shares 720.6m; r=8.35% [WACC [floored]]; 5y FCF grow 3.71% → 2.50% )
EPS Correlation: 96.19 | EPS CAGR: 70.44% | SUE: 0.65 | # QB: 0
Revenue Correlation: 99.31 | Revenue CAGR: 32.29% | SUE: -0.42 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.82 | Chg30d=N/A | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.88 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+107.7% | GrowthRev=+33.9%
EPS next Year (2027-12-31): EPS=3.20 | Chg30d=+2.24% | Revisions=-17% | GrowthEPS=+11.1% | GrowthRev=+15.6%
[Analyst] Revisions Ratio: +0% (up=2, down=2)